Literature DB >> 16734506

The Acne Quality of Life Index (Acne-QOLI): development and validation of a brief instrument.

Stephen R Rapp1, Steven R Feldman, Gloria Graham, Alan B Fleischer, Gretchen Brenes, Maggie Dailey.   

Abstract

BACKGROUND: Acne affects many people and can be detrimental to affected patients' quality of life. Assessing the impact of acne on quality of life requires well-validated and reliable measures of acne-specific quality of life that are brief and easy to administer and interpret.
OBJECTIVES: This paper reports on the development and validation of the Acne Quality of Life Index (Acne-QOLI) for use in clinical care, research, and product development.
METHODS: Focus groups consisting of people from demographically different populations were conducted to identify the most relevant domains of functioning affected by acne; on the basis of these findings, candidate items were developed. An initial item pool of 58 items was included in a survey of 480 persons with mild to severe acne ranging in age from 12 to 62 years. Factor analysis and qualitative analysis were used to reduce the item pool to 21 items. The construct validity, concurrent validity, internal consistency, and test-retest reliability of the items were evaluated.
RESULTS: The 21-item Acne-QOLI showed excellent face validity, content validity, concurrent validity, and construct validity. High internal consistency and test-retest reliability were also found.
CONCLUSIONS: Quality of life is now recognized as an important outcome in medical care. The Acne-QOLI is a brief and easily administered and interpreted measure of acne-related quality of life that can be used in clinical care, research, and product development.

Entities:  

Mesh:

Year:  2006        PMID: 16734506     DOI: 10.2165/00128071-200607030-00005

Source DB:  PubMed          Journal:  Am J Clin Dermatol        ISSN: 1175-0561            Impact factor:   7.403


  9 in total

1.  Quality of Life Perspective Towards Acne among Adolescents at Tertiary Care Center of Gujarat, India.

Authors:  Pragya Ashok Nair; Ashok Raman Nair
Journal:  J Clin Diagn Res       Date:  2015-10-01

Review 2.  Dermatologic health disparities.

Authors:  Kesha J Buster; Erica I Stevens; Craig A Elmets
Journal:  Dermatol Clin       Date:  2012-01       Impact factor: 3.478

3.  Identifying What to Measure in Acne Clinical Trials: First Steps towards Development of a Core Outcome Set.

Authors:  Alison M Layton; E Anne Eady; Diane M Thiboutot; Jerry Tan
Journal:  J Invest Dermatol       Date:  2017-04-27       Impact factor: 8.551

4.  Identifying the Impacts of Acne and the Use of Questionnaires to Detect These Impacts: A Systematic Literature Review.

Authors:  Hayley Smith; Alison M Layton; Diane Thiboutot; Abbey Smith; Heather Whitehouse; Waseem Ghumra; Meenakshi Verma; Jerry Tan; Georgina Jones; Kathryn Gilliland; Megha Patel; Elaine Otchere; Anne Eady
Journal:  Am J Clin Dermatol       Date:  2021-03       Impact factor: 7.403

5.  Quality of life in patients with acne in Erbil city.

Authors:  Kameran Hassan Ismail; Khalis Bilal Mohammed-Ali
Journal:  Health Qual Life Outcomes       Date:  2012-06-06       Impact factor: 3.186

6.  Acne vulgaris and quality of life among young adults in South India.

Authors:  Priya Cinna T Durai; Dhanya G Nair
Journal:  Indian J Dermatol       Date:  2015 Jan-Feb       Impact factor: 1.494

7.  Assessment of Life Quality Index Among Patients with Acne Vulgaris in a Suburban Population.

Authors:  Neirita Hazarika; Radha K Rajaprabha
Journal:  Indian J Dermatol       Date:  2016 Mar-Apr       Impact factor: 1.494

8.  Treatment of erlotinib-induced acneiform eruption with chromophore gel-assisted phototherapy.

Authors:  Akalya Mahendran; Xin L Wong; Steven Kao; Deshan F Sebaratnam
Journal:  Photodermatol Photoimmunol Photomed       Date:  2019-01-06       Impact factor: 3.135

9.  Translation, cultural adaptation and validation for Brazilian Portuguese of the Cardiff Acne Disability Index instrument.

Authors:  Luciana Rosa Grando; Roberta Horn; Vivian Trein Cunha; Tania Ferreira Cestari
Journal:  An Bras Dermatol       Date:  2016-04       Impact factor: 1.896

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.